The late dividing population of γ-retroviral vector transduced human mobilized peripheral blood progenitor cells contributes most to gene-marked cell engraftment in nonobese diabetic/severe combined immunodeficient mice

Stem Cells

Volumn 25, Issue 7, 2007, Pages 1807-1813

  Brenner, Sebastian ^a,b   Ryser, Martin F ^b   Whiting Theobald, Narda L ^a   Gentsch, Marcus ^b   Linton, Gilda F ^a   Malech, Harry L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CYAN FLUORESCENT PROTEIN; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIVISION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENGRAFTMENT; GENETIC TRANSDUCTION; IMMUNE DEFICIENCY; LEUKEMIA; MARKER GENE; MOUSE; MUTAGENESIS; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PROTEIN EXPRESSION; STEM CELL; TRANSGENE;

ADULT; ANIMALS; ANTIGENS, CD; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; DIABETES MELLITUS; FLOW CYTOMETRY; GAMMARETROVIRUS; GENETIC VECTORS; GLYCOPROTEINS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, SCID; PEPTIDES; PHENOTYPE; TIME FACTORS; TRANSDUCTION, GENETIC;

MUS;

EID: 34547174395     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0581     Document Type: Article

References (21)

1. Ueda T, Yoshida M, Yoshino H et al. Hematopoietic capability of CD34+ cord blood cells: A comparison with CD34+ adult bone marrow cells. Int J Hematol 2001;73:457-462.
2. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999;27:1418-1427.
3. Corbeil D, Roper K, Hellwig A et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000;275:5512-5520.
4. Yao CL, Feng YH, Lin XZ et al. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells. Stem Cells Dev 2006;15:70-78.
5. Brenner S, Whiting-Theobald NL, Linton GF et al. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells. Blood 2003;102:2789-2797.
6. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 2000;96:4185-4193.
7. Horwitz ME, Malech HL, Anderson SM et al. Granulocyte colony-stimulating factor mobilized peripheral blood stem cells enter into G1 of the cell cycle and express higher levels of amphotropic retrovirus receptor mRNA. Exp Hematol 1999;27:1160-1167.
8. Berardi AC, Wang A, Levine JD et al. Functional isolation and characterization of human hematopoietic stem cells. Science 1995;267:104-108.
9. Gothot A, van der Loo JC, Clapp DW et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998;92:2641-2649.
10. Habibian HK, Peters SO, Hsieh CC et al. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J Exp Med 1998;188:393-398.
11. Jetmore A, Plett PA, Tong X et al. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood 2002;99:1585-1593.
12. Roesler J, Brenner S, Bukovsky AA et al. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease. Blood 2002;100:4381-4390.
13. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994;68:510-516.
14. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 1996;2:1329-1337.
15. Oostendorp RA, Audet J, Eaves CJ. High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. Blood 2000;95:855-862.
16. Hall KM, Horvath TL, Abonour R et al. Decreased homing of retrovirally transduced human bone marrow CD34(+) cells in the NOD/SCID mouse model. Exp Hematol 2006;34:433-442.
17. Holm M, Thomsen M, Hoyer M et al. Dynamic cell cycle kinetics of normal CD34+ cells and CD38+/- subsets of haemopoietic progenitor cells in G-CSF-mobilized peripheral blood. Br J Haematol 1999;105:1002-1013.
18. Punzel M, Zhang T, Liu D et al. Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cells. Exp Hematol 2002;30:464-472.
19. Reems JA, Torok-Storb B. Cell cycle and functional differences between CD34+/CD38hi and CD34+/38lo human marrow cells after in vitro cytokine exposure. Blood 1995;85:1480-1487.
20. Traycoff CM, Orazi A, Ladd AC et al. Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol 1998;26:53-62.
21. Wagner W, Ansorge A, Wirkner U et al. Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis. Blood 2004;104:675-686.